Azelby Robert
- SEC CIK
- 0001656998
No open-market purchases or sales filed in the past year.
Current role at each company
- AUTL Autolus Therapeutics plcDirectoras of Jul 1, 2026
- TNGX Tango Therapeutics, Inc.Directoras of Jun 23, 2026
- ADCT ADC Therapeutics SADirectoras of Jun 3, 2026
- TERN Terns Pharmaceuticals, Inc.Directoras of May 5, 2026
- CAH Cardinal Health IncDirectoras of Nov 6, 2025
Show 2 more companies
- KDNY Chinook Therapeutics, Inc.Directoras of Aug 11, 2023
- CLYM Climb Bio, Inc.President & CEOas of Nov 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Azelby Robert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADCT ADC Therapeutics SA
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 (view filing) | Jun 17 | 1 day | Azelby RobertDirector | SSale | −7.00K | $2.89 | −$20.2K | −11.7%53.0K after |